Edgewise Therapeutics Inc. logo

Edgewise Therapeutics Inc.

EWTX | NASDAQ
Chart Builder DCF Calculator
$45.66
+$1.02 (+2.28%)
Sep 22, 2026, 12:04 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-167.8M -133.81M -100.16M -67.64M -42.81M -17.12M
Depreciation & Amortization
2.27M 2.29M 1.73M 538K 272K 185K
Stock-Based Compensation
34.75M 24.71M 17.56M 10.92M 4.4M 354K
Other Working Capital
-5.65M 8.59M -1.47M 4.04M 1.98M 1.43M
Other Non-Cash Items
-7.67M -12.55M -9.52M -543K 2.29M n/a
Deferred Income Tax
n/a n/a n/a n/a -2.29M n/a
Change in Working Capital
-5.37M 10.33M -1.56M 4.09M 4.63M 1.95M
Operating Cash Flow
-143.82M -109.03M -91.95M -52.64M -33.51M -14.63M
Capital Expenditures
-256K -1.31M -5.75M -5.55M -668K -203K
Cash Acquisitions
n/a n/a n/a 65.03K 241.56K n/a
Purchase of Investments
-527.23M -477.06M -255.87M -292.39M -288.2M -24.18M
Sales Maturities Of Investments
494.69M 293.71M 364.5M 227.36M 46.64M n/a
Other Investing Acitivies
n/a n/a n/a -65.03K -241.56K n/a
Investing Cash Flow
-32.79M -184.66M 102.89M -70.58M -242.23M -24.38M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 10.11M 548K 474K 236K 202K
Financial Cash Flow
196.09M 249.25M 53.17M 129.64M 186.38M 120.28M
Net Cash Flow
19.48M -44.43M 64.1M 6.43M -89.35M 81.26M
Free Cash Flow
-143.82M -110.34M -97.69M -58.18M -34.18M -14.84M
Adj. Free Cash Flow
-178.57M -135.05M -115.25M -69.11M -38.58M -15.19M
Maintenance CapEx
-256K -1.31M -1.73M -538K -272K -185K
Growth CapEx
n/a n/a -4.01M -5.01M -396K -18K
Owner Earnings
-144.07M -110.34M -93.68M -53.17M -33.78M -14.82M

© 2026 bestshares.com. All rights reserved.